SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-010965
Filing Date
2024-03-13
Accepted
2024-03-13 17:04:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2023proxy-defa14a.htm DEFA14A 43777
2 cumberlandlogoa02a01.jpg GRAPHIC 12534
3 xa01.jpg GRAPHIC 2405
  Complete submission text file 0001628280-24-010965.txt   65617
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33637 | Film No.: 24746894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)